Form 4: Columbia Financial, Inc. Executive Jenifer White Walden Reports Stock and Option Awards
SEC Form 4
EVP & CHRO of Columbia Financial, Inc., Jenifer White Walden, reports acquisition of stock and option awards.
Summary
- On March 3, 2025, Jenifer White Walden, EVP & CHRO of Columbia Financial, Inc., reported the acquisition of 6,521 shares of common stock through a stock award.
- Walden also reported holding various amounts of common stock through a stock-based deferral plan (2,003.6823 shares), ESOP (982 shares), SERP (45 shares), SIM (14 shares), and other stock awards (649, 7,817, and 7,597 shares).
- Additionally, Walden acquired 11,297 stock options with an exercise price of $16.23, vesting in three equal annual installments commencing on March 3, 2026, and expiring on March 3, 2035.
- Walden also holds previously granted stock options with exercise prices of $20.54, $15.94, and $16.49, vesting at various dates.
Sentiment
Score: 5
Explanation: This is a neutral report on executive stock and option awards, with no inherent positive or negative implications.
Positives
- The granting of stock and option awards to executives aligns their interests with those of the shareholders.
- The vesting schedules of the awards encourage long-term commitment from the executive.
Industry Context
This filing is a routine disclosure of executive compensation in the financial services industry, where stock and option awards are common tools for incentivizing performance and retaining key personnel.
Comparison to Industry Standards
- Executive compensation packages, including stock and option awards, are standard practice in the financial services industry.
- Companies like JPMorgan Chase, Bank of America, and Wells Fargo also utilize equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and performance-based criteria are typical features of such awards, designed to incentivize long-term performance.
Stakeholder Impact
- The granting of stock options and awards can potentially align executive interests with shareholder value.
- Employees may be impacted through the ESOP and other stock-based plans.
Key Dates
| Date | Description |
|---|---|
| 10/31/2023 | Stock Options ($20.54) vest in three equal annual installments commencing on this date. |
| 05/01/2024 | Stock Options ($15.94) vest in three approximately equal annual installments commencing on this date. |
| 03/06/2025 | 25% of Stock Awards vest in three approximately equal annual installments commencing on this date; Stock Options ($16.49) vest in three approximately equal annual installments commencing on this date. |
| 03/03/2025 | Date of transaction for stock and option awards. |
| 03/03/2026 | Stock Options ($16.23) vest in three approximately equal annual installments commencing on this date. |
| 03/06/2034 | Expiration date for Stock Options with exercise price of $16.49. |
| 05/01/2033 | Expiration date for Stock Options with exercise price of $15.94. |
| 10/31/2032 | Expiration date for Stock Options with exercise price of $20.54. |
| 03/03/2035 | Expiration date for Stock Options with exercise price of $16.23. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.